Doctors Revision

Principles of Infectious Disease: Pathogens, Host Response and Pathogenesis

Text size
On this page

Overview

DCM 3101 • LWA 1 • Sub-topic 1.2

Infection is the establishment of a foreign organism in or on a host. It may remain as colonisation, progress to tissue injury and clinical disease, or become an opportunistic or endogenous infection when host defences are impaired. The clinical student must understand the organism, the host response and the transmission context together — infectious disease is always an interaction, never just a microbe.

Learning outcomes

  • Classify infectious agents and relate their biology to clinical disease.
  • Explain normal flora, colonisation resistance and endogenous infection.
  • Describe the six links in the chain of infection.
  • Explain pathogenicity, virulence factors, toxins, invasion, biofilm and intracellular survival.
  • Relate innate and adaptive responses to fever, inflammation, organ dysfunction and recovery.

Infection as an interaction

Colonisation may occur without overt tissue injury — think of staphylococci on the skin or streptococci in the throat. Infectious disease occurs when the interaction between pathogen and host produces damage and clinical illness. Communicable disease is transmitted between hosts; endogenous disease arises from organisms already colonising the patient; opportunistic infection occurs when natural defence is compromised by HIV, malnutrition, malignancy, immunosuppressive medicine, diabetes, invasive devices or other conditions. This is why the same organism can be harmless on one patient’s skin and fatal in another’s bloodstream.

Groups of infectious agents

Scroll the table sideways on a smaller screen.

Groups of infectious agents
AgentKey biologyClinical principle
PrionsAbnormally folded proteins without nucleic acid; induce abnormal folding of normal host proteinCause transmissible spongiform encephalopathies; not treatable like bacteria or viruses and resist standard sterilisation
VirusesDNA or RNA in a capsid, sometimes with a lipid envelope; depend on host cells for replicationEnveloped viruses (HIV, influenza) are environmentally fragile; non-enveloped viruses (rotavirus, adenovirus) survive better on surfaces
BacteriaProkaryotes with Gram-positive and Gram-negative cell wallsCapsules, plasmids, flagella, spores and endotoxin influence disease and treatment
FungiEukaryotes as yeasts, moulds or dimorphic forms; membranes contain ergosterolSuperficial, systemic and opportunistic disease differ in host risk and therapy
ProtozoaUnicellular eukaryotes, often with complex life cycles or vectorsTravel, water, food, vector exposure and immune status guide diagnosis (malaria, amoebiasis, trypanosomiasis)
HelminthsMulticellular parasites: nematodes, trematodes, cestodesDisease reflects tissue migration, adult worm burden, eggs and the host immune response

Koch’s postulates

The classical postulates linked a microorganism to a disease by finding it in every case, isolating it, reproducing the disease in a susceptible host and recovering the organism again. They remain historically important but do not apply fully to organisms that cannot be cultured (Treponema pallidum), agents that require specific host cells (viruses), members of normal flora (many endogenous infections) or diseases with multiple causes. Modern evidence adds molecular detection (PCR, sequencing), serology, epidemiological association and experimental models.

Normal flora and colonisation resistance

Humans carry large communities of resident and transient microorganisms. Resident flora survive and replicate at a body site; transient flora remain briefly. Normal flora can be mutualistic, commensal or parasitic depending on the interaction. They contribute vitamins, occupy attachment sites, lower local pH, produce bacteriocins and stimulate protective antibodies. Antibiotics, surgery, immune suppression and barrier damage can cause overgrowth, translocation or cross-infection — this loss of colonisation resistance is why broad-spectrum antibiotics so often precede Clostridioides difficile colitis or candida overgrowth.

Pathogenicity, infectivity, virulence

  • Pathogenicity is the capacity to cause disease; infectivity is the capacity to establish infection; virulence is the degree of harm.
  • Primary pathogens can cause disease in healthy hosts; opportunistic pathogens generally require impaired defence.
  • Virulence factors include adhesins, capsules, motility, invasins, enzymes, toxins, antigenic variation, immune evasion and nutrient-acquisition mechanisms (e.g., siderophores).
  • Plasmids, bacteriophages, mutation, recombination and horizontal gene transfer can change pathogenicity and antimicrobial resistance — resistance genes travel between bacteria, not only between generations.

Establishing disease: six steps

  1. Adherence: adhesins bind host receptors and determine tissue tropism.
  2. Colonisation: the organism survives local pH, oxygen, nutrients, mucus, flow and competing flora.
  3. Invasion: organisms cross epithelium, enter tissue or exploit wounds, devices and injections.
  4. Multiplication and dissemination: spread through contiguous tissue, lymph, blood, nerves or vectors.
  5. Tissue injury: direct cytotoxicity, nutrient theft, obstruction, invasion, toxins or immune-mediated damage.
  6. Persistence: latency, intracellular survival, biofilm and antigenic change permit chronic or recurrent disease.

Toxins and microbial injury

Endotoxin is chiefly the lipopolysaccharide of the Gram-negative outer membrane, released during bacterial damage or lysis, and causes broad inflammatory effects. Exotoxins are proteins released by living bacteria that produce specific effects on target cells. Toxin-mediated disease may be severe even when the organism is no longer present at the site of injury.

Scroll the table sideways on a smaller screen.

Endotoxin versus exotoxin
FeatureEndotoxinExotoxin
NatureLipopolysaccharide (LPS) of Gram-negative outer membraneSecreted proteins, Gram-positive and Gram-negative
Heat stabilityHeat-stableUsually heat-labile
EffectsFever, hypotension, disseminated intravascular coagulation, shockHighly specific: neurotoxins (tetanus, botulinum), cytotoxins (diphtheria), enterotoxins (cholera)
Toxoid vaccine possible?NoYes (tetanus, diphtheria toxoids)
Disease when organism absentLysis can release it; disease tracks with bacterial burdenYes — clinical effect may persist after the organism is cleared

Intracellular pathogens and biofilm

Viruses replicate inside cells. Some bacteria (Mycobacterium tuberculosis, Salmonella typhi, Listeria), parasites (Leishmania, Toxoplasma) and fungi (Histoplasma) survive within macrophages or other cells after phagocytosis — one reason they need prolonged, cell-penetrating therapy. Biofilms are communities embedded in an extracellular matrix on teeth, prostheses, catheters and other surfaces; organisms in biofilms communicate, exchange genes and become up to a thousand-fold less accessible to immune cells and antimicrobials. Device removal or source control may therefore be as important as drug choice — antibiotics alone rarely cure an infected central line.

Host defence

Scroll the table sideways on a smaller screen.

Host defences against infection
DefenceExamplesClinical importance
Physical and chemical barriersSkin, mucosa, mucus, cilia, cough, gastric acid, bile, urine flowBreaks, burns, catheters, obstruction and aspiration increase risk
Normal floraCompetition, pH change, bacteriocins and immune primingAntibiotics can remove colonisation resistance
Innate immunityNeutrophils, macrophages, complement, NK cells, pattern receptors and cytokinesFast response; excessive activation can injure tissue
Adaptive immunityAntibodies, B cells, T cells, memory and cellular cytotoxicitySpecific protection; humoral or cellular defects change the pathogen spectrum (e.g., encapsulated bacteria after splenectomy, CMV and fungi with T-cell defects)

Host response, harm and fever

Clinical manifestations reflect both microbial virulence and the host response. Cytokines and antimicrobial factors help contain infection but may damage tissue: excess inflammation causes fever, hypotension, capillary leak, thrombosis, acute lung injury and organ dysfunction — the physiology of sepsis. Immune reconstitution inflammatory syndrome (IRIS) shows the paradox clearly: when antiretroviral therapy restores immunity in an HIV patient with occult tuberculosis or cryptococcosis, the recovering immune response can transiently worsen inflammation against the persisting pathogen.

Fever and systemic inflammation: microbial and endogenous pyrogens stimulate monocytes and macrophages to release IL-1, TNF and IL-6, which alter hypothalamic thermoregulation through prostaglandin E₂ (the target of paracetamol and NSAIDs). Rigors occur when the body abruptly raises its core temperature set-point. Interpret fever with age, immune status, antipyretic use, perfusion and organ function — absence of fever does not exclude severe infection, especially in neonates, the elderly, malnourished and immunosuppressed patients.

Chain of infection

Communicable transmission requires six links: infectious agent → reservoir → portal of exit → mode of transmission → portal of entry → susceptible host. Prevention works by breaking any link. For a respiratory infection, ventilation and masks affect transmission; vaccination and prophylaxis protect the host; effective treatment reduces the reservoir and communicability. In Uganda this framework explains malaria control (vector link: bed nets, indoor spraying), cholera control (water and sanitation links) and HIV prevention (blood, sexual transmission and treatment-as-prevention links).

Bedside antimicrobial principles

  1. Identify the syndrome and its severity before naming an organism (e.g., “community-acquired pneumonia, severe” guides empiric cover before any culture result).
  2. Obtain a good specimen — blood cultures, urine, sputum, pus, CSF — before antimicrobials when this is safe, but never delay resuscitation in septic shock.
  3. Use local guidance and antimicrobial stewardship: narrow, stop or change treatment when evidence returns; document indication, route and review date (“antibiotic time-out” at 48–72 hours).
  4. Protect the patient, staff and community with standard precautions and transmission-based measures (contact, droplet, airborne).
  5. Control the source: drain abscesses, remove infected devices, relieve obstruction — antibiotics cannot sterilise an undrained pus collection or an infected catheter biofilm.
  6. Reassess response daily: defervescence, falling white count, improving perfusion; consider non-infectious mimics and complications if the patient is not responding.

Clinical scenario

Scenario 1 — The dialysis catheter that keeps growing the same organism

A 60-year-old man with end-stage renal disease on haemodialysis through a tunneled central venous catheter presents with fever and rigors during his third consecutive session. Two blood cultures grow Staphylococcus epidermidis with the same antibiotic susceptibility pattern as last month, when he completed two weeks of flucloxacillin and “got better”. This is the biofilm principle in action: the catheter lumen harbours a Staph. epidermidis biofilm that antibiotics penetrate poorly, so bloodstream infection relapses whenever the course stops. Management: take paired blood cultures (peripheral and through the line), start empirical therapy per local protocol (e.g., vancomycin for coagulase-negative staphylococci with high cloxacillin resistance), and — critically — remove or exchange the catheter because source control, not a longer antibiotic course, is what cures device-associated biofilm infection. In a resource-limited setting where line salvage is sometimes attempted, discuss the relapse risk explicitly with the patient.

Scenario 2 — Fever without fever

A 78-year-old malnourished man with advanced HIV (not on antiretroviral therapy) is brought in confused, with a temperature of 36.1 °C, tachycardia 124/min, blood pressure 88/50 mmHg and a cough. No fever — but this is sepsis until proved otherwise: hypothermia, not hyperthermia, is common in severe infection at the extremes of age and in immunosuppression. Recognise the syndrome, take cultures without delaying treatment, start oxygen, IV fluids and empirical antibiotics per the sepsis pathway within the first hour, and investigate for tuberculosis, pneumocystis and bacterial pneumonia as the underlying causes.

Key points

References

  • SlideShare: 15 Principles of Infectious Disease (Library reference.)
  • Davidson’s Principles and Practice of Medicine (Library reference.)
  • Mims’ Medical Microbiology (Library reference.)
  • WHO resources on infection prevention and antimicrobial resistance (Library reference.)

Further reading

For deeper study, compare this lesson with current guidance and standard references from recognised medical and public-health organisations.

For education only. Apply current Uganda Clinical Guidelines, local protocols and specialist advice in clinical practice.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top